BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20410334)

  • 21. Treatment options for surgically resectable gastric cancer.
    Rajdev L
    Curr Treat Options Oncol; 2010 Jun; 11(1-2):14-23. PubMed ID: 20358316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
    Ajani JA; Winter K; Okawara GS; Donohue JH; Pisters PW; Crane CH; Greskovich JF; Anne PR; Bradley JD; Willett C; Rich TA
    J Clin Oncol; 2006 Aug; 24(24):3953-8. PubMed ID: 16921048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical morbidity and mortality after neoadjuvant chemotherapy in the CRITICS gastric cancer trial.
    Claassen YHM; Hartgrink HH; Dikken JL; de Steur WO; van Sandick JW; van Grieken NCT; Cats A; Trip AK; Jansen EPM; Meershoek-Klein Kranenbarg WM; Braak JPBM; Putter H; van Berge Henegouwen MI; Verheij M; van de Velde CJH
    Eur J Surg Oncol; 2018 May; 44(5):613-619. PubMed ID: 29503129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemoradiation therapy versus chemotherapy alone for gastric cancer after R0 surgical resection: a meta-analysis of randomized trials.
    Min C; Bangalore S; Jhawar S; Guo Y; Nicholson J; Formenti SC; Leichman LP; Du KL
    Oncology; 2014; 86(2):79-85. PubMed ID: 24435019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.
    Badgwell B; Blum M; Estrella J; Chiang YJ; Das P; Matamoros A; Fournier K; Mansfield P; Ajani J
    J Am Coll Surg; 2015 Jul; 221(1):83-90. PubMed ID: 26002780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer.
    Bang YJ; Van Cutsem E; Fuchs CS; Ohtsu A; Tabernero J; Ilson DH; Hyung WJ; Strong VE; Goetze TO; Yoshikawa T; Tang LH; Hwang PMT; Webb N; Adelberg D; Shitara K
    Future Oncol; 2019 Mar; 15(9):943-952. PubMed ID: 30777447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
    Yu W
    Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Gastric cancer: current status of multimodality treatment].
    Meyer HJ; Wilke H
    Zentralbl Chir; 2011 Aug; 136(4):317-24. PubMed ID: 21789757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The UK NCRI MAGIC trial of perioperative chemotherapy in resectable gastric cancer: implications for clinical practice.
    Chua YJ; Cunningham D
    Ann Surg Oncol; 2007 Oct; 14(10):2687-90. PubMed ID: 17653804
    [No Abstract]   [Full Text] [Related]  

  • 30. Gastric cancer in Asia: progress and controversies in surgical management.
    Branicki FJ; Chu KM
    Aust N Z J Surg; 1998 Mar; 68(3):172-9. PubMed ID: 9563443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant and neoadjuvant therapy for gastric cancer.
    Gonzalez RJ; Mansfield PF
    Surg Clin North Am; 2005 Oct; 85(5):1033-51, viii. PubMed ID: 16139035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Laparoscopic gastrectomy combined with neoadjuvant chemotherapy for gastric cancer patients: from the view of the CLASS-03a trial].
    Hu J; Zhang W; Chen X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):138-142. PubMed ID: 29492910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perspectives of surgery and multimodality treatment in gastric carcinoma.
    Meyer HJ; Jähne J; Wilke H
    J Cancer Res Clin Oncol; 1993; 119(7):384-94. PubMed ID: 8491758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MAGIC versus MacDonald treatment regimens for gastric cancer: Trends and predictors of multimodal therapy for gastric cancer using the National Cancer Database.
    Jayanathan M; Erwin RP; Molacek N; Fluck M; Hunsinger M; Wild J; Arora TK; Shabahang MM; Franko J; Blansfield JA
    Am J Surg; 2020 Jan; 219(1):129-135. PubMed ID: 31262435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of multimodality treatment: two and four courses of neoadjuvant chemotherapy using S-1/CDDP or S-1/CDDP/docetaxel followed by surgery and S-1 adjuvant chemotherapy for macroscopically resectable serosa-positive gastric cancer: a randomized phase II trial (COMPASS-D trial).
    Yoshikawa T; Taguri M; Sakuramoto S; Kunisaki C; Fukunaga T; Ito S; Cho H; Tanabe K; Nishikawa K; Matsui T; Morita S; Tsuburaya A
    Jpn J Clin Oncol; 2012 Jan; 42(1):74-7. PubMed ID: 22102736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multimodality treatment of potentially curative gastric cancer: geographical variations and future prospects.
    Merrett ND
    World J Gastroenterol; 2014 Sep; 20(36):12892-9. PubMed ID: 25278686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative chemotherapy with cisplatin and docetaxel followed by surgery and clip-oriented postoperative chemoradiation in patients with localized gastric or gastroesophageal junction adenocarcinoma: results from a phase II feasibility study.
    Spizzo G; Öfner D; de Vries A; Lukas P; Steger G; Pluschnig U; Zacherl J; Widder J; Zabernigg A; Gastl G; Mühlmann G
    Ann Surg Oncol; 2011 Mar; 18(3):677-83. PubMed ID: 21063792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma.
    Cohen DJ; Newman E; Iqbal S; Chang RY; Potmesil M; Ryan T; Donahue B; Chandra A; Liu M; Utate M; Hiotis S; Pachter LH; Hochster H; Muggia F
    Ann Surg Oncol; 2012 Feb; 19(2):478-85. PubMed ID: 21769462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
    Varadhachary G; Ajani JA
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adjuvant therapy after curative resection with D2 lymphadenectomy for gastric cancer: results of a prospective clinical trial].
    Markelis R; Endzinas Z; Kiudelis M; Grizas S; Pundzius J; Saladzinskas Z; Juozaityte E; Inciūra A; Pranys D; Maleckas A
    Medicina (Kaunas); 2009; 45(6):460-8. PubMed ID: 19605966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.